Category Specific RSS

Categories: News

Food Revolution pivots into hand sanitiser production, shares surge 49%

With a bottling production plant already in operation, food processing company Food Revolution Group (ASX: FOD) has received enough interest in hand sanitiser to quickly commission a new bottling line to fill a global supply gap in the sanitary product. 

Whilst the company does not have a line of sanitary products, its Melbourne plant has the capacity to produce and bottle numerous products including gels, powders and oils. Commissioning of the new line is already underway as customers in China seek to contain the coronavirus outbreak. 

Within its bottling line, Food Revolution has the capacity to fill bottles up to 4 litres with the machine confirmed as suitable for alcohol-based hand sanitiser. It will be the same multi-purpose machine which the company also uses for bottling canola oil. 

The new line of sanitary products will be produced by Food Revolution under their new ‘Sanicare’ brand, with production expected to commence before the end of February and be distributed by Careline Australia, FOD’s distribution partner. 

“The versatility of FOD’s upgraded plant with clean room and bottling capacity to meet the substantial demands of the Chinese market is evidenced by these developments and vindicates the company’s decision to invest in the new clean room factory to provide constant supply of high quality Australian products to the Chinese market,” said Food Revolution Chairman, Dr Norman Li. 

The majority of the new Sanicare products will be sent directly to China where there is unprecedented demand for hand sanitiser but Food Revolution will look to continue sanitiser production complementary to their established food products. 

To facilitate the additional production, two more machines have been built in China for Food Revolution’s new clean room factory which will enable powder sachet packaging and gel sachet packaging. 

Following news of the new Sanicare production line, shares in Food Revolution rocketed to an intra-day high of $0.085, a rise of 49% on the previous day’s close of $0.057. 

Alfred Chan

Alfred Chan is a Business Reporter at The Sentiment specialising in ASX-listed small cap companies, a bloodstock enthusiast and former equities analyst.

Recent Posts

Biotron Expands into Anaesthetics with Sedarex Acquisition and $2.5m Raise

Biotech company Biotron Limited (ASX:BIT) has announced a bold step into the anaesthetics sector, acquiring…

5 days ago

DroneShield Boosts Defence Capability with $13 Million Adelaide R&D Investment

DroneShield (ASX:DRO) is expanding its Australian footprint with a $13 million investment to establish a…

2 weeks ago

Stakk Secures T-Mobile Contract to Power Super App Expansion

Australian fintech Stakk (ASX:SKK) has signed a three-year agreement with U.S. telecommunications giant T-Mobile USA,…

3 weeks ago

Medibank Backs Emyria with Landmark Depression Care Deal

Australia’s mental health burden is growing – and one of the toughest challenges is treatment-resistant…

4 weeks ago

NoviqTech Launches Quantum Intelligence Products, Opening Path to Enterprise-Grade Quantum AI

NoviqTech Limited (ASX:NVQ) has taken a decisive step into the quantum computing market, unveiling the…

1 month ago

BRE Wins Final Permit to Advance Rare Earth Pilot Plant in Brazil

Brazilian Rare Earths Limited (ASX:BRE) has cleared its last regulatory hurdle to begin pilot operations…

2 months ago